This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Jack E. Ansell, MD; Neal Patel; Daniel Ostrovsky; Elaine Nozzolillo, BSN; Ann Marie Peterson, MSN; Lynn Fish

Arch Intern Med. 1995;155(20):2185-2189.

Abstract
Background
The management of oral anticoagulation is fraught with difficulties. This study assessed a new model of anticoagulation management regarding the ability, safety, and efficacy of patients to self-monitor and self-adjust the dose of their oral anticoagulants guided by a capillary whole-blood prothrombin time (PT) monitor.

Methods
This investigation is a retrospective cohort study of 20 patients compared with 20 matched control patients receiving oral anticoagulation at a tertiary medical institution.

Results
Study patients monitored their PTs 2153 times during a mean interval of 44.7 months compared with 1608 PTs in matched control patients during a mean interval of 42.5 months. Study patients made an average of 11.5 dosage changes per patient, contrasted with 22.7 changes per control patient (P<.001). The PTs in study patients were within the recommended therapeutic range in 88.6% (95% confidence interval, 87.2 to 89.9) of the determinations compared with 68.0% (95% confidence interval, 65.7 to 70.3; P<.001) of the determinations made by the matched control patients. In response to the 2153 PTs, study patients made 67 (3.1%) dosage decisions that were considered incorrect based on physician guidelines. None of these changes led to adverse outcomes. There was no significant difference in complication rates between the two groups.

Conclusions
Results from what is the first long-term study of patient self-monitoring of PTs and self-adjustment of the warfarin sodium dosage for oral anticoagulation suggest that patients can successfully measure their own PTs, adjust their own warfarin dosage, and achieve a degree of therapeutic effectiveness at least as good, if not better than patients managed in an anti- coagulation clinic. Larger, prospective, randomized trials are needed to confirm the efficacy and safety of this new approach to therapy and to assess its cost-effectiveness.

(Arch Intern Med. 1995;155:2185-2189)

Author Affiliations
From the Department of Medicine and Anticoagulation Service, University of Massachusetts Medical School, Worcester.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

An Interpretative Phenomenological Analysis of Adaptation to Recurrent Venous Thrombosis and Heritable Thrombophilia: The Importance of Multi-causal Models and Perceptions of Primary and Secondary Control
Moore et al.
J Health Psychol 2008;13:776-784.
ABSTRACT  

Self-managed oral anticoagulation therapy
Marasinghe and Amarasinghe
CMAJ 2007;176:813-813.
FULL TEXT  

Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy.
Regier et al.
CMAJ 2006;174:1847-1852.
ABSTRACT | FULL TEXT  

Devices for ambulatory and home monitoring of blood pressure, lipids, coagulation, and weight management, part 2
Scolaro et al.
Am J Health Syst Pharm 2005;62:1894-1903.
ABSTRACT | FULL TEXT  

In defence of current treatment options: where are we now?
Voller
Eur Heart J Suppl 2005;7:E4-E9.
FULL TEXT  

Anticoagulation Monitoring Part 1: Warfarin and Parenteral Direct Thrombin Inhibitors
Spinler et al.
The Annals of Pharmacotherapy 2005;39:1049-1055.
ABSTRACT | FULL TEXT  

Economic factors associated with antithrombotic treatments for stroke prevention in patients with atrial fibrillation
Miller et al.
Eur Heart J Suppl 2005;7:C41-C54.
ABSTRACT | FULL TEXT  

Comparing Self-Management of Oral Anticoagulant Therapy with Clinic Management: A Randomized Trial
Menendez-Jandula et al.
ANN INTERN MED 2005;142:1-10.
ABSTRACT | FULL TEXT  

The Pharmacology and Management of the Vitamin K Antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Ansell et al.
Chest 2004;126:204S-233S.
ABSTRACT | FULL TEXT  

Hemorrhagic Complications of Anticoagulant Treatment: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Levine et al.
Chest 2004;126:287S-310S.
ABSTRACT | FULL TEXT  

Self-management Education Programs in Chronic Disease: A Systematic Review and Methodological Critique of the Literature
Warsi et al.
Arch Intern Med 2004;164:1641-1649.
ABSTRACT | FULL TEXT  

The Value of Home Monitoring Kits in Diabetes, Hypertension, Asthma, and Oral Anticoagulation Therapy
Vincze and Parthan
Journal of Pharmacy Practice 2004;17:182-196.
ABSTRACT  

Comparison of the Quality of Oral Anticoagulant Therapy Through Patient Self-management and Management by Specialized Anticoagulation Clinics in the Netherlands: A Randomized Clinical Trial
Gadisseur et al.
Arch Intern Med 2003;163:2639-2646.
ABSTRACT | FULL TEXT  

Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial
Wilson et al.
CMAJ 2003;169:293-298.
ABSTRACT | FULL TEXT  

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy
Hirsh et al.
J Am Coll Cardiol 2003;41:1633-1652.
FULL TEXT  

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy
Hirsh et al.
Circulation 2003;107:1692-1711.
FULL TEXT  

Mechanical heart valve patients can manage oral anticoagulant therapy themselves
Christensen et al.
Eur. J. Cardiothorac. Surg. 2003;23:292-298.
ABSTRACT | FULL TEXT  

A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management
Fitzmaurice et al.
J. Clin. Pathol. 2002;55:845-849.
ABSTRACT | FULL TEXT  

Home management of anticoagulation
Voller et al.
Eur Heart J Suppl 2001;3:Q44-Q49.
ABSTRACT  

Economic analysis of bleeding and thromboembolic sequelae after heart valve replacement (GELIA 7)
Muller et al.
Eur Heart J Suppl 2001;3:Q65-Q69.
ABSTRACT  

Anticoagulation in patients with thromboembolic disease
Tait
Thorax 2001;56:ii30-37.
FULL TEXT  

Point-of-Care Coagulation Testing: Stepping Gently Forward
Laposata
Clin. Chem. 2001;47:801-802.
FULL TEXT  

A nurse led clinic and computer decision support system for anticoagulation decisions was at least as effective as a hospital clinic
Wright
Evid. Based Nurs. 2001;4:57-57.
FULL TEXT  

Thrombophilia: What's a Practitioner to Do?
Macik et al.
ASH Education Book 2001;2001:322-338.
ABSTRACT | FULL TEXT  

Managing Oral Anticoagulant Therapy
Ansell et al.
Chest 2001;119 :22S-38S.
FULL TEXT  

Advances in Therapy and the Management of Antithrombotic Drugs for Venous Thromboembolism
Ansell et al.
ASH Education Book 2000;2000:266-284.
ABSTRACT | FULL TEXT  

A Structured Teaching and Self-management Program for Patients Receiving Oral Anticoagulation: A Randomized Controlled Trial
Sawicki and for the Working Group for the Study of Patient Sel
JAMA 1999;281:145-150.
ABSTRACT | FULL TEXT  

Empowering Patients to Monitor and Manage Oral Anticoagulation Therapy
Ansell
JAMA 1999;281:182-183.
FULL TEXT  

Initiating and Maintaining Patients on Warfarin Anticoagulation: The Importance of Monitoring
Ezekowitz et al.
J CARDIOVASC PHARMACOL THER 1999;4:3-8.
ABSTRACT  

Comparison of an Anticoagulation Clinic With Usual Medical Care: Anticoagulation Control, Patient Outcomes, and Health Care Costs
Chiquette et al.
Arch Intern Med 1998;158:1641-1647.
ABSTRACT | FULL TEXT  

An Analysis of the Lowest Effective Intensity of Prophylactic Anticoagulation for Patients with Nonrheumatic Atrial Fibrillation
Hylek et al.
NEJM 1996;335:540-546.
ABSTRACT | FULL TEXT  

Can Patients Manage Oral Anticoagulation?
Journal Watch Cardiology 1996;1996:15-15.
FULL TEXT  

CAN PATIENTS MANAGE ORAL ANTICOAGULATION?
JWatch General 1995;1995:4-4.
FULL TEXT